cytidine diphosphate choline has been researched along with Orthomyxoviridae Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Davis, IC; Doolittle, LM; El-Musa, H; Hickman-Davis, JM; Hite, RD; Joseph, LM; Novotny, MV; Rosas, LE | 1 |
Calomeni, EP; Davis, IC; Doolittle, LM; Joseph, LM; Rosas, LE; Woods, PS | 1 |
2 other study(ies) available for cytidine diphosphate choline and Orthomyxoviridae Infections
Article | Year |
---|---|
Postexposure Liponucleotide Prophylaxis and Treatment Attenuates Acute Respiratory Distress Syndrome in Influenza-infected Mice.
Topics: Alveolar Epithelial Cells; Animals; COVID-19; COVID-19 Drug Treatment; Cytidine Diphosphate Choline; Cytidine Diphosphate Diglycerides; Influenza A Virus, H1N1 Subtype; Mice; Orthomyxoviridae Infections; Respiratory Distress Syndrome; SARS-CoV-2 | 2021 |
Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome.
Topics: Alveolar Epithelial Cells; Animals; Bronchoalveolar Lavage Fluid; Cell Separation; Cholesterol; Cytidine Diphosphate Choline; Influenza A Virus, H1N1 Subtype; Lipid Metabolism; Metabolome; Mice, Inbred C57BL; Orthomyxoviridae Infections; Phospholipids; Pulmonary Surfactants | 2016 |